YSOPIA Bioscience

Leading biotech in the development of innovative #microbiome-based therapies

[YSOPIA Bioscience @YSOPIA_Bio]

Antimicrobial resistant bacteria are present in newborns after just a few hours of life and they help to understand the routes of transmission of antibiotic-resistance genes.
👉 https://t.co/ChBwnKnAQY

[YSOPIA Bioscience @YSOPIA_Bio]

Know more about the role of gut microbiota in health and diseases.
👉 https://t.co/6VIzPz6tjZ

[YSOPIA Bioscience @YSOPIA_Bio]

Discover in this study results highlighting the importance of incorporating the human gut microbiome in our understanding of SARS-CoV-2 infection and disease progression.
👉 https://t.co/dGieYadVj3

[YSOPIA Bioscience @YSOPIA_Bio]

SARS-CoV-2: A new study published in Gut Microbes underscored the significance of fiber-fermenting gut bacteria that release short-chain fatty acids, which limit viral entry and hypercoagulation and induce an immune-mediated antiviral response.
https://t.co/uIjglOEIEY

[YSOPIA Bioscience @YSOPIA_Bio]

Discover in this study how honeybees have been used to probe the effect of the gut microbiota on their host social behaviour.
https://t.co/kyMGi0upR9

[YSOPIA Bioscience @YSOPIA_Bio]

The idea behind Live Bacterial Therapeutics (LBTs) is to engineer bacterial hosts to produce therapeutics able to repair or restore healthy microbial function and diversity.
👉Read more in this article https://t.co/qbR0fgpZ3a

[YSOPIA Bioscience @YSOPIA_Bio]

This study explores how nourishing gut bacteria with the right foods will generate the necessary short-chain fatty acids that protect against, or reduce, symptoms in a variety of conditions.
https://t.co/f6YBR0wZJI

[YSOPIA Bioscience @YSOPIA_Bio]

This study provides a gut microbial genome reference set that can serve as a valuable resource for further research.
https://t.co/imhZJFxJXd

[YSOPIA Bioscience @YSOPIA_Bio]

This study demonstrates that gut bacteria help the immune system recover from stem cell transplants by nurturing two special types of immune cells that protect against complications.
https://t.co/kyEugTKBNV

[YSOPIA Bioscience @YSOPIA_Bio]

In this recent study published in the journal Advanced Science, researchers explored the dynamic changes in the respiratory tract and gut microbiota in COVID-19 patients.

Find out more: https://t.co/8RRsdAUTQ5

[YSOPIA Bioscience @YSOPIA_Bio]

Discover how YSOPIA Bioscience unleashes microbiome-based biotherapies and join us in our journey to fight diseases such as #obesity, #crohndisease, metabolic diseases, cancer
👉 https://t.co/YXrnYk8KWP

[YSOPIA Bioscience @YSOPIA_Bio]

Discover findings providing insight into the respiratory tract and gut microbial dynamics during COVID-19 progression, considering disease severity, potentially contributing to diagnosis, and treatment strategies.

Find our more: https://t.co/6zB2GODsEN

[YSOPIA Bioscience @YSOPIA_Bio]

Humans living an urbanized lifestyle in industrialized countries tend to have less diverse microbiota than people living more rural existences. Find out more in this study https://t.co/1eXRu3unN9

[YSOPIA Bioscience @YSOPIA_Bio]

📅 Meet us at Microbiome Connect in Amsterdam.
Fréderic Elustondo, Senior Director of Operations, will discuss the preparation of our christensenella minuta-based anaerobic bacteria Xla1 for clinical trial.
Join Fréderic on July 6th at 3.20pm
More info: https://t.co/WIrirb6eE9

[YSOPIA Bioscience @YSOPIA_Bio]

[ #WorldMicrobiomeDay ] As a clinical-stage biotech leading next-generation microbiome-based living biotherapies, YSOPIA Bioscience is proud to be part of the visionary minds of the Future of the Microbiome!

[European Microbiome Innovation for Health @EMIH_EU]

[#MEMBER] @maat_pharma Confirms Positive Results from Completed Phase 1b CIMON Study Evaluating MaaT033 in Blood #Cancer Patients #microbiome
➡https://t.co/LnZ39XQow5

[YSOPIA Bioscience @YSOPIA_Bio]

Scientists find your gut is significantly different from #hunter-gather communities and the difference starts to emerge as early as six months since birth.

#Read more : https://t.co/Kv96wxX6jt

[YSOPIA Bioscience @YSOPIA_Bio]

Type 2 diabetes is a highly prevalent metabolic disorder.
💡 Discover how YSOPIA Bioscience harness the potential of Christensenella gut bacteria to treat obesity and associated metabolic diseases.
https://t.co/GTcvbhqP9C

[YSOPIA Bioscience @YSOPIA_Bio]

People with #Parkinson’s disease appear to have a gut microbiome — the population of microorganisms living in the intestines — that is shifted toward a pro-inflammatory state, a small study suggests.

Find out more about the study : https://t.co/wJq9RIcuVS

[European Microbiome Innovation for Health @EMIH_EU]

[#NEWS] 📢 Discover the recent scientific publication "Robust variation in infant #gut #microbiome assembly across a spectrum of lifestyles" from @ScienceMagazine
➡https://t.co/S2oqbehmhO